These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23869062)

  • 1. Estrogen replacement and skeletal muscle: mechanisms and population health.
    Tiidus PM; Lowe DA; Brown M
    J Appl Physiol (1985); 2013 Sep; 115(5):569-78. PubMed ID: 23869062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis.
    Javed AA; Mayhew AJ; Shea AK; Raina P
    JAMA Netw Open; 2019 Aug; 2(8):e1910154. PubMed ID: 31461147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials.
    Bea JW; Zhao Q; Cauley JA; LaCroix AZ; Bassford T; Lewis CE; Jackson RD; Tylavsky FA; Chen Z
    Menopause; 2011 Jan; 18(1):44-52. PubMed ID: 20689466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
    Manson JE; Bassuk SS; Kaunitz AM; Pinkerton JV
    Menopause; 2020 Aug; 27(8):918-928. PubMed ID: 32345788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
    Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
    PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative.
    Bhupathiraju SN; Grodstein F; Rosner BA; Stampfer MJ; Hu FB; Willett WC; Manson JE
    Am J Epidemiol; 2017 Sep; 186(6):696-708. PubMed ID: 28938710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal health interventions: Time to move on from the Women's Health Initiative?
    Thaung Zaw JJ; Howe PRC; Wong RHX
    Ageing Res Rev; 2018 Dec; 48():79-86. PubMed ID: 30355506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
    Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
    Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between hormone therapy use and changes in strength and body composition in early postmenopausal women.
    Maddalozzo GF; Cardinal BJ; Li F; Snow CM
    Menopause; 2004; 11(4):438-46. PubMed ID: 15243282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New evidence for cardiac benefit of postmenopausal hormone therapy.
    Mikkola TS; Savolainen-Peltonen H; Venetkoski M; Ylikorkala O
    Climacteric; 2017 Feb; 20(1):5-10. PubMed ID: 28042727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hormone therapy on women's quality of life in the first year of the Estonian Postmenopausal Hormone Therapy trial.
    Veerus P; Hovi SL; Sevón T; Hunter M; Hemminki E
    BMC Res Notes; 2012 Apr; 5():176. PubMed ID: 22472039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transdermal estrogen on collagen turnover at rest and in response to exercise in postmenopausal women.
    Pingel J; Langberg H; Skovgård D; Koskinen S; Flyvbjerg A; Frystyk J; Kjær M; Hansen M
    J Appl Physiol (1985); 2012 Oct; 113(7):1040-7. PubMed ID: 22773769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopause and postmenopausal hormone therapy and risk of hearing loss.
    Curhan SG; Eliassen AH; Eavey RD; Wang M; Lin BM; Curhan GC
    Menopause; 2017 Sep; 24(9):1049-1056. PubMed ID: 28486246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
    Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
    Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future.
    Clarkson TB; Meléndez GC; Appt SE
    Menopause; 2013 Mar; 20(3):342-53. PubMed ID: 23435033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy and skeletal muscle strength: a meta-analysis.
    Greising SM; Baltgalvis KA; Lowe DA; Warren GL
    J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1071-81. PubMed ID: 19561145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.